|
|
Volumn 6, Issue 5, 2005, Pages 261-
|
|
Sirolimus does double duty after organ transplantation
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
CYCLOSPORIN A;
RAPAMYCIN;
VASCULOTROPIN;
ANTINEOPLASTIC ACTIVITY;
CANCER INHIBITION;
CANCER RISK;
CAUSE OF DEATH;
CLINICAL TRIAL;
COMORBIDITY;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
FOLLOW UP;
GRAFT FAILURE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
IMMUNOTHERAPY;
KAPOSI SARCOMA;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LONG TERM CARE;
NOTE;
PRIORITY JOURNAL;
RISK REDUCTION;
SKIN BIOPSY;
TREATMENT OUTCOME;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
NEOPLASMS;
SARCOMA, KAPOSI;
SIROLIMUS;
|
|
EID: 17844361895
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(05)70146-7 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|